Virometix virometix.com


Public lists: Pharma Startups (4729)

Virometix is a biotechnology company developing vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. Rational molecular design, chemical synthesis, and Virometix' proprietary Synthetic Virus-Like Particle platform technology allow for the rapid production and optimization of vaccine candidates with superior properties in terms of safety, efficacy, and stability. Virometix is a spin-out company from the University of Zurich.

Virometix is a biotechnology company developing vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. Rational molecular design, chemical synthesis, and Virometix' proprietary Synthetic Virus-...Show all

Company (Alive / Active)

Phone: +41 (0) 43 433 86 60

Fax:

Wagisstrasse 14

Schlieren, CH-8952
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Virometix $6.4M Sep 5, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Virometix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Proline-rich peptides protective against s. pneumoniae Dec 02, 2014 Application